In Canada, Oligo Medic, a medical device company that develops biomaterials for regenerative medicine and is known for JointRep for cartilage treatment in body joints, has a new CEO, Jerett A. Creed. Creed’s career started with Johnson and Johnson focusing on angioplasty balloons and metal stents, as CFO of a publicly traded oil and gas company and CEO of Cardigant Medical, but has evolved with his 20 years of experience in the medical technology field. Creed led Oligo Medic’s launch of their JointRep product in Latin America. He has also been involved in 2 public offerings as well as more than $650 million merger and acquisition activities for Oligo Medic.
Latest article
Bio-hybrid robot made from langoustine shells works like arcade claw crane
In Switzerland, scientists at École Polytechnique Fédérale de Lausanne have converted shellfish shells into claws that grip, not unlike the prize-filled claw machines found...
Holy Carp! makes waves as biodegradable single-use soy sauce alternative
In Australia, design studios Heliograf and Vert Design have jointly developed a biodegradable alternative to whimsical—but polluting—plastic fish-shaped soy sauce containers often seen with...
Pineapple hair ties win Fowler Business Concept Challenge
In California, a University of San Diego graduate student has won a $15,000 scholarship to advance her pineapple leaf hair ties.
Sage Dobby, who...